Lobe Sciences Ltd.
LOBEF · OTC
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | $5,130 | $2,603 | $2,382 | $800 |
| - Cash | $4,259 | $238 | $140 | $908 |
| + Debt | $199 | $1,747 | $333 | $0 |
| Enterprise Value | $1,070 | $4,112 | $2,574 | -$107 |
| Revenue | $0 | $136 | $841 | $0 |
| % Growth | -100% | -83.8% | – | – |
| Gross Profit | $0 | $134 | $817 | -$10 |
| % Margin | – | 98.7% | 97.1% | – |
| EBITDA | -$3,103 | -$4,116 | -$4,420 | -$4,113 |
| % Margin | – | -3,021.9% | -525.9% | – |
| Net Income | -$3,221 | -$4,421 | -$4,707 | -$12,253 |
| % Margin | – | -3,245.8% | -560% | – |
| EPS Diluted | -0.023 | -0.036 | -0.045 | -0.32 |
| % Growth | 35.9% | 19.7% | 85.9% | – |
| Operating Cash Flow | -$1,031 | -$462 | -$1,719 | -$2,731 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,031 | -$462 | -$1,719 | -$2,731 |